Literature DB >> 15690143

Evaluation of joints using Tc 99m-MDP bone scintigraphy in patients with familial Mediterranean fever: should bone scans be used for diagnosis and follow-up?

Mustafa Yildiz1, S Ercan Tunc, Mehmet Sahin, Berna Okudan, Osman Aydin, Harun Suslu, Meltem Ozbek.   

Abstract

Familial Mediterranean fever (FMF) is an autosomal recessively-inherited disorder typically manifested by recurrent attacks of fever and polyserositis. The articular disease occurs in 50-70% of patients. Bone scintigraphy is more sensitive in the diagnosis of arthritis than clinical examination or conventional radiological imaging, allowing earlier diagnosis through the visualization of disease in multiple sites. To assess joint involvements in FMF patients with or without joint symptoms, bone scintigraphy was performed in 36 patients with FMF and in 25 controls. There was arthritis in 72% of patients. Of these, 65% knee, 42% ankle, 50% sacroiliac, 8% elbow, 8% wrist, 4% sternoclavicular and 4% hip involvements were found. The sacroiliac joints with sacroiliac index higher than 1.34 were diagnosed as sacroiliitis, which was higher than 2 SD of normal. FMF is frequently associated with joint disease such as knee and ankle arthritis and sacroiliitis. This high incidence of sacroiliitis in our study has not been previously reported. This difference could be explained by the different methodology used for the screening of the joints. Thus, we recommend that bone scintigraphy can be used in patients with FMF to determine the presence of arthritis, especially in sacroiliac joints, even asymptomatic.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15690143     DOI: 10.1007/s00296-004-0555-9

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  16 in total

1.  Roentgenologic findings in familial Mediterranean fever.

Authors:  N SHAHIN; E SOHAR; F DALITH
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1960-08

2.  Radiographic changes in the sacroiliac joints in familial Mediterranean fever.

Authors:  P A Brodey; S M Wolff
Journal:  Radiology       Date:  1975-02       Impact factor: 11.105

Review 3.  Nuclear medicine techniques in arthritis.

Authors:  L Rosenthall
Journal:  Rheum Dis Clin North Am       Date:  1991-08       Impact factor: 2.670

Review 4.  The bone scan: where are we now?

Authors:  P J Ryan; I Fogelman
Journal:  Semin Nucl Med       Date:  1995-04       Impact factor: 4.446

5.  Criteria for the diagnosis of familial Mediterranean fever.

Authors:  A Livneh; P Langevitz; D Zemer; N Zaks; S Kees; T Lidar; A Migdal; S Padeh; M Pras
Journal:  Arthritis Rheum       Date:  1997-10

Review 6.  Familial Mediterranean fever.

Authors:  Aysin Bakkaloglu
Journal:  Pediatr Nephrol       Date:  2003-06-27       Impact factor: 3.714

7.  HLA-B27-negative sacroiliitis: a manifestation of familial Mediterranean fever in childhood.

Authors:  T J Lehman; V Hanson; H Kornreich; R S Peters; A D Schwabe
Journal:  Pediatrics       Date:  1978-03       Impact factor: 7.124

8.  Effect of imaging time on the values of the sacroiliac index.

Authors:  D Dodig; Z Domljan; S Popović; I Simonović
Journal:  Eur J Nucl Med       Date:  1988

9.  The clinical patterns of arthritis in children with familial Mediterranean fever.

Authors:  H A Majeed; M Rawashdeh
Journal:  QJM       Date:  1997-01

10.  The arthritis of familial Mediterranean fever (FMF).

Authors:  H Heller; J Gafni; D Michaeli; N Shahin; E Sohar; G Ehrlich; I Karten; L Sokoloff
Journal:  Arthritis Rheum       Date:  1966-02
View more
  3 in total

1.  Spondyloarthritis in familial Mediterranean fever: a cohort study.

Authors:  Sevtap Acer Kasman; Mehmet Tuncay Duruöz
Journal:  Rheumatol Int       Date:  2022-06-18       Impact factor: 3.580

2.  The frequency of sacroiliitis in familial Mediterranean fever and the role of HLA-B27 and MEFV mutations in the development of sacroiliitis.

Authors:  Timuçin Kaşifoğlu; Cüneyt Calişir; Döndü U Cansu; Cengiz Korkmaz
Journal:  Clin Rheumatol       Date:  2008-09-16       Impact factor: 2.980

3.  Intramuscular gold for the treatment of seronegative spondyloarthropathy associated with familial Mediterranean fever.

Authors:  Mehmet D Demirag; Mehmet A Ozturk; Berna Goker; Seminur Haznedaroglu
Journal:  Rheumatol Int       Date:  2008-07-01       Impact factor: 2.631

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.